Short Interest in SanBio Company Limited (OTCMKTS:SNBIF) Drops By 17.9%

SanBio Company Limited (OTCMKTS:SNBIF) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 515,000 shares, a decrease of 17.9% from the September 30th total of 627,100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

SanBio Price Performance

Shares of OTCMKTS SNBIF remained flat at C$3.85 during mid-day trading on Wednesday. The business has a 50 day simple moving average of C$3.85 and a 200-day simple moving average of C$3.85. SanBio has a 1-year low of C$3.80 and a 1-year high of C$4.25.

About SanBio

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.